Briefing.com vahendusel:
Ülespoole avanevad:
In reaction to strong earnings/guidance: MCBC +46.1%, PWER +18.5%, ALU +11.2%, MXWL +10.6%, TUNE +10.3%, HLIT +8.9% (light volume), DDIC +6.5%, AXTI +6.3%, CPSI +6.3%, TRID +6.1%, QSFT +5.8%, GPRO +5.0% (light volume), IXYS +4.5% (light volume), EMN +4.2%, SUN +4.1%, ACI +4.0%, SWIR +3.6%, MET +3.5%, ROVI +3.4%, MXIM +3.3%, EXPE +3.0%, HTHT +2.3% (light volume), TSRA +2.2%, AXL +1.7%, SYNA +1.0%.
M&A news: CRL +6.4% (Charles River and WuXi PharmaTech to terminate their previously announced acquisition agreement; CRL approves $500 mln stock repurchase plan),.
Other news: GERN +13.3% (to proceed with first human clinical trial of embryonic stem cell-based therapy), OREX +10.5% (reported patients taking Contrave were two to three times more likely to lose at least 5-10% of their body weight compared to those taking placebo), HLCS +7.0% (thinly traded; confirms publication of demonstration using Helicos' single-molecule sequencing technology), SHOO +3.2% (will replace inVentiv Health in the S&P SmallCap 600 index), SOLR +3.5% (acquires Sapphire Producer Crystal Systems for $24 mln in cash, 5.4 mln shares of common stock, and a $21 mln cash earn-out), NFLX +3.0% (early strength attributed to upgrade at tier 1 firm), BIDU +1.0% (says web search service availability in China fully blocked, according to CNBC).
Analyst comments: AU +1.1% (initiated with a Hold at Citigroup), ARRS +0.9% (upgraded to Hold from Underperform at Jefferies).
Allapoole avanevad:
In reaction to disappointing earnings/guidance: TNAV -29.4% (also downgraded to Neutral from Overweight at JP Morgan), APKT -14.0%, THOR -13.0%, WFR -11.2% (also downgraded to Underperform from Buy at Credit Agricole, downgraded to Sell from Buy at Wunderlich), VITC -9.5%, CAVM -9.3%, WPCS -9.3% (thinly traded), TSYS -9.2%, LNET -9.1% (light volume), NTRI -8.8%, CSTR -8.5%, FNBN -6.3% (thinly traded), CNXT -6.0%, AUTH -5.2% (light volume), GNW -3.7%, CTCT -3.4%, WYNN -3.2%, OCLR -2.8%, MRK -2.2%, FSLR -2.0%, VALE -1.1%, AMGN -1.0%, PTV -0.9%.
M&A news: WX -2.4% (Charles River and WuXi PharmaTech to terminate their previously announced acquisition agreement).
Select financial related names showing weakness: RDN -4.8%, ING -3.7%, IRE -2.5%, AIB -2.4%, NBG -2.4%, RF -2.4%, MBI -2.1%, BBT -1.8%, MI -1.7%, HBAN -1.7%, WFC -1.6%, FITB -1.5%, C -1.5%, BPOP -1.4%, MS -1.4%.
Select metals/mining stocks trading lower: MT -2.1%, RTP -1.7%, BBL -1.7%, BHP -1.4%.
Select solar names under pressure following FSLR results: JASO -2.5%, SOLF -2.4%, TSL -2.3%, LDK -2.0%, SPWRA -1.7% (light volume).
Other news: GFRE -8.0% (files for $120 mln mixed securities shelf offering), TLAB -3.9% (still checking), GOOG -1.0% (says web search service availability in China fully blocked, according to CNBC), LVS -0.9% (trading lower with WYNN).
Analyst comments: TSYS -4.6% (downgraded to Perform from Outperform at Oppenheimer), BJ -2.3% (downgraded to Neutral from Outperform at Cowen), HAL -2.0% (downgraded to Market Perform from Outperform at FBR Capital), SHPGY -1.4% (downgraded to Market Perform from Outperform at Bernstein), CL -0.8% (downgraded to Neutral from Buy at Goldman- removed from Conviction Buy list).